chlorambucil has been researched along with Group A Strep Infection in 1 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Excerpt | Relevance | Reference |
---|---|---|
"Pyomyositis has become an increasingly recognized disease in temperate climates." | 2.37 | Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature. ( Baum, S; Minor, RL; Schulze-Delrieu, KS, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Minor, RL | 1 |
Baum, S | 1 |
Schulze-Delrieu, KS | 1 |
1 review available for chlorambucil and Group A Strep Infection
Article | Year |
---|---|
Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature.
Topics: Chlorambucil; Female; Humans; Middle Aged; Myositis; Scleroderma, Systemic; Streptococcal Infections | 1988 |